Pharma pill manufacturing

Biovian announces investment in manufacturing facility in Finland

Betsy Goodfellow | July 26, 2023 | News story | Manufacturing and Production Biovian, Pharmacy, facility, manufacturing 

Biopharmaceutical based contract development and manufacturing organisation (CDMO) Biovian OY has announced an investment of over €50m to expand its manufacturing facility based in Turku, Finland.

The facility is expected to cover 6,400sqm and will be home to cutting-edge equipment and technology aiming to support the development, manufacturing and testing of advanced therapy medicinal products (ATMP) therapies. It will also house dedicated class A to D cleanroom areas for bulk drug substances and final drug product manufacturing.

The expansion is expected to be completed by December 2024, with the facility intended to become fully operational by 2025.

Advertisement

Antti Nieminen, Biovian’s chief executive officer, commented: “The new manufacturing facility will not only strengthen Biovian’s position as a key player in the CDMO sector, but also contribute to the growth of the biopharmaceutical industry in Finland, and most of all provide vital therapies to patients suffering from today’s untreatable diseases. Biovian aims to facilitate swift drug development and delivery, reducing time-to-market for its customers, all while creating an enjoyable experience. The new manufacturing facility will increase viral vector capacity, but it will also increase our capacity and flexibility in microbial protein. When the new site is up and running, our existing capacity will be transformed to new microbial protein suites. Thus, both microbial and viral vector customers will benefit from this expansion.”

Betsy Goodfellow

Related Content

CARBOGEN AMCIS manufacturing license advances services in China

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has …

Meribel Pharma Solutions launches to take pharma services to new heights

Meribel Pharma Solutions, a new mid-sized contract development and manufacturing organisation (CDMO), has officially launched …

Bend Bioscience adds commercial spray drying facility to Georgia site

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …

The Gateway to Local Adoption Series

Latest content